CVS Health Corporation (BVL:CVSUS)
Peru · Delayed Price · Currency is PEN · Price in USD | Market Cap | 375.38B +10.6% |
| Revenue (ttm) | 1.43T +6.8% |
| Net Income | 37.86B +2,253.3% |
| EPS | 29.53 +2,214.0% |
| Shares Out | n/a |
| PE Ratio | 9.94 |
| Forward PE | 9.95 |
| Dividend | 9.18 (3.13%) |
| Ex-Dividend Date | Oct 22, 2026 |
| Volume | 480 |
| Open | 85.30 |
| Previous Close | 82.28 |
| Day's Range | 85.30 - 85.30 |
| 52-Week Range | 75.00 - 107.61 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 4, 2026 |
About CVS Health
CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care prov... [Read more]
Financial Performance
In 2025, CVS Health's revenue was $399.83 billion, an increase of 7.87% compared to the previous year's $370.66 billion. Earnings were $1.77 billion, a decrease of -61.68%.
Financial numbers in USD Financial StatementsNews
CVS Has Not Received Offers For the Retail Pharmacy Business, CEO Says
CVS Health Chief Executive Officer and Chairman David Joyner says no offers have been received yet for its retail pharmacy business which is being spun off in the first half of next year. The company'...
CVS Health CEO says hasn’t received offers to buy pharmacies
CVS Health (CVS) CEO David Joyner made the comments while being interviewed on Bloomberg Television.
CVS Pharmacy® makes holiday shopping easier with gifts for every list, budget and celebration
WOONSOCKET, R.I., Nov. 9, 2026 /PRNewswire/ -- CVS Pharmacy®, the retail division of CVS Health® (NYSE: CVS), is helping shoppers take on the holidays with gifts, décor, stocking stuffers, personalize...
CVS Health Transcript: 8th Annual Wolfe Research Healthcare Conference
The planned separation is intended to create two investment-grade businesses with independent growth paths, with ongoing dis-synergies expected nearer $500 million than estimates above $1 billion. Retail pharmacy targets reimbursement stabilization and adjacent-service growth, while Medicare and PBM recovery continue through 2027-28.
CVS Health price target lowered to $103 from $120 at Raymond James
Raymond James analyst John Ransom lowered the firm’s price target on CVS Health (CVS) to $103 from $120 and keeps an Outperform rating on the shares. CVS Health’s planned retail…
Here's how CVS' breakup of its pharmacy and insurance empire could affect consumers
CVS' recent decision to divide its retail pharmacies from its insurance and pharmacy-benefit operations has raised hopes of consumer savings as Americans continue to reel from high costs of living.
CVS Health price target lowered to $100 from $110 at BofA
BofA analyst Allen Lutz lowered the firm’s price target on CVS Health (CVS) to $100 from $110 and keeps a Buy rating on the shares. CVS reported a “strong” Q3,…
CVS Health price target lowered to $107 from $118 at UBS
UBS lowered the firm’s price target on CVS Health (CVS) to $107 from $118 and keeps a Buy rating on the shares.
CVS Health plans to create more focused firms with breakup, WSJ says
CVS Health’s (CVS) plan to break off its drugstores from the Aetna health-insurance unit and Caremark pharmacy-benefit manager is intended to create more focused firms, Anna Wilde Mathews and Alexande...
CVS announces major breakup, pharmacy expert weighs impact on consumers
CVS Health breakup will create separate pharmacy and health care companies as industry expert weighs the impact on prescription drug prices, pharmacies and patients.
CVS Health price target lowered to $107 from $108 at Barclays
Barclays lowered the firm’s price target on CVS Health (CVS) to $107 from $108 and keeps an Overweight rating on the shares.
Inside CVS Health, a small group of top executives spent months engaged in a strategic review that developed into a secret plan: a decision to split up the $400 billion healthcare giant
The company is splitting its drugstore and insurance businesses amid mounting regulatory pressure.
Wednesday's Final Takeaways: CVS Splitting in Two, ORCL Scraps Tencent Deal
CVS Health (CVS) will divide its healthcare empire into two separate businesses. Meanwhile, Oracle (ORCL) shaves off new contracts by scrapping its tentative deal with Tencent.
CVS is splitting into two companies: Healthcare giant's ‘Pharmacy' breakup explained
CVS is breaking up.
CVS Health plans to split itself up. Here's why a breakup could make sense now
CVS Health announced plans to split into two publicly traded companies by the first half of 2028, separating its pharmacy business from its insurer, Aetna, and pharmacy benefit manager, Caremark. Anal...
CVS Health price target lowered to $110 from $125 at Evercore ISI
Evercore ISI analyst Elizabeth Anderson lowered the firm’s price target on CVS Health (CVS) to $110 from $125 and keeps an Outperform rating on the shares. The firm notes CVS…
CVS Dismantling Healthcare Empire: Regulatory Tailwinds v. Cost Headwinds
CVS Health (CVS) plans to separate its retail pharmacy and insurance businesses. Brian Tanquilut, a Jefferies healthcare analyst, says this could help CVS adapt to regulatory change.
CVS Health to split pharmacy chain from health insurance
CVS Pharmacy will be separate from CVS Health, housing major insurer Aetna and benefits manager Caremark
CVS Health says cost of split contemplated, included in guidance
Says confident that any dis-synergies can be managed. Says making the split from a position of strength.
CVS Health sees FY27 adjusted EPS ‘at least’ $8.65, consensus $8.54
08:15 EST CVS Health (CVS) sees FY27 adjusted EPS ‘at least’ $8.65, consensus $8.54
CVS Health raises FY26 revenue view to ‘at least’ $420B, consensus $417.87B
Prior view was “at least” $414B. Guidance from Q3 conference call.
CVS Health says strong execution has ‘significantly strengthened’ balance sheet
Expects to resume share repurchases in Q4. Says confident in adequacy of reserves. Says successfully navigating elevated trends. Says has achieved leverage goal ahead of target date. Comments taken fr...
CVS Health Earnings Call Transcript: Q3 2026
Q3 adjusted EPS was $2.09, up over 30% YoY, and FY 2026 adjusted EPS guidance rose to at least $8.20. A planned H1 2028 separation will create an integrated healthcare solutions business and CVS Pharmacy, with 2027 adjusted EPS expected at least $8.65.
CVS Health Earnings release: Q3 2026
CVS Health released its Q3 2026 earnings on November 4, 2026, summarizing the period's financial results.
CVS Health Quarterly report: Q3 2026
CVS Health has published its Q3 2026 quarterly earnings report on November 4, 2026.